(Q44595395)

4 December 2017

title

Placebo and Nocebo responses, cortisol, and circulating beta-endorphin (English)

1 reference

4 December 2017

Placebo and Nocebo Responses, Cortisol, and Circulating Beta-Endorphin (English)

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

14 March 2024

0 references

0 references

1 reference

1 reference

Oddmund Johansen

1

1 reference

4 December 2017

Jan Brox

2

1 reference

4 December 2017

Magne Arve Flaten

3

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

https://journals.lww.com/10.1097/01.PSY.0000082626.56217.CF

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

14 March 2024

published in

Psychosomatic Medicine

1 reference

4 December 2017

volume

65

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

786-790

1 reference

The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia

4 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Influence of the method of drug administration on analgesic response

14 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm.

14 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Pain and emotion: effects of affective picture modulation.

14 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Partial antagonism of placebo analgesia by naloxone

14 March 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Beta-endorphin in the immune system--mediator of pain and stress?

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Local analgesic effect of endogenous opioid peptides

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

The Response of Plasma Immunoreactive Adrenocorticotropin, β-Endorphin/β-Lipotropin, γ-Lipotropin and Cortisol to Experimentally Induced Pain in Normal Subjects

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Pituitary control of immune cells

14 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes

14 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception

14 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Expectations of analgesia do not affect spinal nociceptive R-III reflex activity: an experimental study into the mechanism of placebo-induced analgesia.

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Somatotopic activation of opioid systems by target-directed expectations of analgesia.

14 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes

14 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Prospective validation of clinically important changes in pain severity measured on a visual analog scale

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Conditioned response models of placebo phenomena: further support

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Impact of experimentally-induced expectancy on the analgesic efficacy of tramadol in chronic pain patients: a 2 x 2 factorial, randomized, placebo-controlled, double-blind trial

14 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

Clinicians' expectations influence placebo analgesia

14 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/01.PSY.0000082626.56217.CF

14 March 2024

Identifiers

1 reference

4 December 2017

1 reference